Trial Number: RTOG 0813
Phase: Phase I/II
[View Details]

Study Title: Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients

Trial Number: 09085
Phase: Phase II
[View Details]

Study Title: A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II.5 Study of AZD0530, a Selective Src Kinase Inhibitor, in Patients with Recurrent Osteosarcoma Localized to the Lung

Trial Number: 08653
Phase: Phase II
[View Details]

Study Title: A Phase 2, Open-label Study of IMC-1121B in Combination with Paclitaxel and Carboplatin as First-line Therapy in Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Trial Number: CALGB 30901
Phase: Phase II
[View Details]

Study Title: Randomized Phase II Study of Maintenance Pemetrexed Versus Observation for Patients With Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Trial Number: 08656
Phase: Phase II
[View Details]

Study Title: An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma

Trial Number: RTOG 0915
Phase: Phase II
[View Details]

Study Title: A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage 1 Peripheral Non-Small Cell Lung Cancer

Trial Number: 08657
Phase: Phase II
[View Details]

Study Title: A Phase 2, Open Label, Trial of PF-00299804 in Selected Patients with Untreated Advanced Adenocarcinoma of the Lung

Trial Number: CTSU E1505-CIRB
Phase: Phase III
[View Details]

Study Title: A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage IB (>/= 4cm) ¿ IIIA Non-Small Cell Lung Cancer (NSCLC)

Trial Number: RTOG 0617/NCCTG N0628/CALGB 30609
Phase: Phase III
[View Details]

Study Title: A Randomized Phase III Comparison of Standard-Dose (60Gy) Versus High-Dose (74Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444)in Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer

Trial Number: 08655
Phase: Phase III
[View Details]

Study Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of ASA404 in Combination with Docetaxel in Second-Line Treatment of Patients with Locally Advanced or Metastatic (stage IIIb/IV) Non-Small Cell Lung Cancer (NSCLC)